⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 16, 2024American Journal of Health-System Pharmacy

DPYD testing makes fluoropyrimidine chemotherapy safer

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Journal Article DPYD testing makes fluoropyrimidine chemotherapy safer Get access Kate Traynor Kate Traynor ktraynor@ashp.org Search for other works by this author on: Oxford Academic Google Scholar American Journal of Health-System Pharmacy, Volume 81, Issue 9, 1 May 2024, Pages e197–e198, https://doi.org/10.1093/ajhp/zxae058 Published: 16 March 2024 Article history Corrected and typeset: 16 March 2024 Published: 16 March 2024

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kate Traynor (2024) studied this question.

synapsesocial.com/papers/68e73b9db6db6435876b55a6 https://doi.org/10.1093/ajhp/zxae058

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Implementation of <i>DPYD</i> genotyping in response to FDA black box warning: Initial experience at a comprehensive cancer center.Original Research · 2026
2Global Investigation of Clinical Implementation Strategies for <scp> <i>DPYD</i> </scp> Testing to Guide Fluoropyrimidine TherapyOriginal Research · 2025 · 8 citations
3<i>DPYD</i> testing in GI cancers: A real-world analysis of costs and quality of care.Original Research · 2026 · 1 citations
4Evaluation of Clinical Implementation of Prospective <i>DPYD</i> Genotyping in 5-Fluorouracil- or Capecitabine-Treated Patientscohort · 2016 · 30 citations
54CPS-230 Identification of rare DPYD variants associated with toxicity to fluoropyrimidines in a clinical pharmacogenomics programme2024

Improving dihydropyrimidine dehydrogenase genotyping (DPYD) prior to initiation of fluoropyrimidine-based chemotherapy at a community-based hospital: A quality improvement initiative.2024
Impact of pharmacist-driven DPYD genotype-guided dosing for fluoropyrimidine-based chemotherapy regimens.2025
Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (<i>DPYD</i>) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer Center2024
Carbapenem–valproic acid derivative drug-drug interactions: Evaluation of a pharmacist-facing OurPractice AdvisoryAmerican Journal of Health-System Pharmacy · 2026
Hiring Alone Won’t Close the Gap: Redesigning the Health-System Pharmacy WorkforceAmerican Journal of Health-System Pharmacy · 2026

More from American Journal of Health-System Pharmacy